85 related articles for article (PubMed ID: 19778445)
1. The rapamycin-regulated gene expression signature determines prognosis for breast cancer.
Akcakanat A; Zhang L; Tsavachidis S; Meric-Bernstam F
Mol Cancer; 2009 Sep; 8():75. PubMed ID: 19778445
[TBL] [Abstract][Full Text] [Related]
2. Protein interacting with C alpha kinase 1 (PICK1) is involved in promoting tumor growth and correlates with poor prognosis of human breast cancer.
Zhang B; Cao W; Zhang F; Zhang L; Niu R; Niu Y; Fu L; Hao X; Cao X
Cancer Sci; 2010 Jun; 101(6):1536-42. PubMed ID: 20384629
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer prognosis by combinatorial analysis of gene expression data.
Alexe G; Alexe S; Axelrod DE; Bonates TO; Lozina II; Reiss M; Hammer PL
Breast Cancer Res; 2006; 8(4):R41. PubMed ID: 16859500
[TBL] [Abstract][Full Text] [Related]
4. Identification of RAD54 homolog B as a promising therapeutic target for breast cancer.
Feng J; Hu J; Xia Y
Oncol Lett; 2019 Nov; 18(5):5350-5362. PubMed ID: 31612045
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex.
Lu Y; Zhang EY; Liu J; Yu JJ
Orphanet J Rare Dis; 2020 Aug; 15(1):209. PubMed ID: 32807195
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Li X; Wang Y; Li B; Ma W
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
[TBL] [Abstract][Full Text] [Related]
7. TOR Facilitates the Targeting of the 19S Proteasome Subcomplex To Enhance Transcription Complex Assembly at the Promoters of the Ribosomal Protein Genes.
Uprety B; Kaja A; Bhaumik SR
Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29712756
[TBL] [Abstract][Full Text] [Related]
8. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
9. Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.
Di Gialleonardo V; Aldeborgh HN; Miloushev V; Folkers KM; Granlund K; Tap WD; Lewis JS; Weber WA; Keshari KR
Cancer Res; 2017 Jun; 77(11):3113-3120. PubMed ID: 28386017
[TBL] [Abstract][Full Text] [Related]
10. Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.
Hassan B; Akcakanat A; Sangai T; Evans KW; Adkins F; Eterovic AK; Zhao H; Chen K; Chen H; Do KA; Xie SM; Holder AM; Naing A; Mills GB; Meric-Bernstam F
Oncotarget; 2014 Sep; 5(18):8544-57. PubMed ID: 25261369
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Zhang H; Cohen AL; Krishnakumar S; Wapnir IL; Veeriah S; Deng G; Coram MA; Piskun CM; Longacre TA; Herrler M; Frimannsson DO; Telli ML; Dirbas FM; Matin AC; Dairkee SH; Larijani B; Glinsky GV; Bild AH; Jeffrey SS
Breast Cancer Res; 2014 Apr; 16(2):R36. PubMed ID: 24708766
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
13. Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines.
Pénzváltó Z; Tegze B; Szász AM; Sztupinszki Z; Likó I; Szendrői A; Schäfer R; Győrffy B
PLoS One; 2013; 8(3):e59503. PubMed ID: 23555683
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.
Sangai T; Akcakanat A; Chen H; Tarco E; Wu Y; Do KA; Miller TW; Arteaga CL; Mills GB; Gonzalez-Angulo AM; Meric-Bernstam F
Clin Cancer Res; 2012 Oct; 18(20):5816-28. PubMed ID: 22932669
[TBL] [Abstract][Full Text] [Related]
15. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression.
Hall BA; Kim TY; Skor MN; Conzen SD
Breast Cancer Res Treat; 2012 Sep; 135(2):469-79. PubMed ID: 22842983
[TBL] [Abstract][Full Text] [Related]
16. Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types.
Gundem G; Lopez-Bigas N
Genome Med; 2012 Mar; 4(3):28. PubMed ID: 22458606
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
Meric-Bernstam F; Akcakanat A; Chen H; Do KA; Sangai T; Adkins F; Gonzalez-Angulo AM; Rashid A; Crosby K; Dong M; Phan AT; Wolff RA; Gupta S; Mills GB; Yao J
Clin Cancer Res; 2012 Mar; 18(6):1777-89. PubMed ID: 22422409
[TBL] [Abstract][Full Text] [Related]
18. Poly (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell lines.
Carraro DM; Ferreira EN; de Campos Molina G; Puga RD; Abrantes EF; Trapé AP; Eckhardt BL; Nunes DN; Brentani MM; Arap W; Pasqualini R; Brentani H; Dias-Neto E; Brentani RR
PLoS One; 2011; 6(6):e21022. PubMed ID: 21731642
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of chinese propolis on phosphatidylcholine-specific phospholipase C activity in vascular endothelial cells.
Xuan H; Zhu R; Li Y; Hu F
Evid Based Complement Alternat Med; 2011; 2011():985278. PubMed ID: 20981295
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
Luyimbazi D; Akcakanat A; McAuliffe PF; Zhang L; Singh G; Gonzalez-Angulo AM; Chen H; Do KA; Zheng Y; Hung MC; Mills GB; Meric-Bernstam F
Mol Cancer Ther; 2010 Oct; 9(10):2770-84. PubMed ID: 20876744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
